The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

HCP Inc

NYSE: HCP
Last

(U.S.) $28.03

Today's change-5.96 -17.55%
Updated February 9 1:50 PM EST. Delayed by at least 15 minutes.
 

HCP Inc

NYSE: HCP
Last

(U.S.) $28.03

Today's change-5.96 -17.55%
Updated February 9 1:50 PM EST. Delayed by at least 15 minutes.

HCP Inc down (U.S.)$5.96

HCP Inc is sharply lower today, dropping (U.S.)$5.96 or 17.55% to (U.S.)$28.03. Over the last five days, shares have lost 21.80% and are down 26.71% for the last year to date. This security has underperformed the S&P 500 by 25.63% during the last year.

Key company metrics

  • Open(U.S.) $32.15
  • Previous close(U.S.) $33.99
  • High(U.S.) $32.16
  • Low(U.S.) $28.00
  • Bid / Ask(U.S.) $28.02 / (U.S.) $28.03
  • YTD % change-26.71%
  • Volume8,701,045
  • Average volume (10-day)4,302,803
  • Average volume (1-month)4,064,115
  • Average volume (3-month)3,680,019
  • 52-week range(U.S.) $28.00 to (U.S.) $44.79
  • Beta0.32
  • Trailing P/E55.17×
  • P/E 1 year forward59.63×
  • Forward PEG22.94×
  • Indicated annual dividend(U.S.) $2.30
  • Dividend yield8.21%
  • Trailing EPS(U.S.) $0.51
Updated February 9 1:50 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.76%

Based on its net profit margin of 10.76%, HCP Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.60%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue658608611604
Total other revenue--------
Total revenue658608611604
Gross profit484471479473
Total cost of revenue174136132130
Total operating expense400349753271
Selling / general / administrative21292520
Research & development--------
Depreciation / amortization135120115116
Interest expense (income), net operating--------
Unusual expense (income)71634824
Other operating expenses, total--------
Operating income258259-142333
Interest income (expense), net non-operating-122-119-117-115
Gain (loss) on sale of assets0063
Other--------
Income before tax135151-251223
Income after tax137156-251225
Income tax, total-2-50-3
Net income115165-241197
Total adjustments to net income0000
Net income before extra. items115165-241197
Minority interest-3-3-3-3
Equity in affiliates-191214-26
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items115165-241196
Inc. avail. to common incl. extra. items115165-241196
Diluted net income115165-241196
Dilution adjustment0000
Diluted weighted average shares464462461460
Diluted EPS excluding extraordinary itemsvalue per share0.250.36-0.520.43
Dividends per sharevalue per share0.570.570.570.55
Diluted normalized EPSvalue per share0.350.440.150.43